Establishing Pediatric CNS Pharmacodynamic Measures as Tools to Enable Psychiatric Indications in Adolescents
| Country | United States |
|---|---|
| Deadline | Not published |
| Published | 2025-09-12 |
| Sectors | Health & life sciences |
| Source | Grants.gov (US) |
Summary
Funding opportunity PAR-26-049. CFDA: 93.242
The buyer, the value, the full description and the link to the official notice are available with a free account.